Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Recruiting × Low Grade Serous Ovarian Carcinoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 298 Carcinoma, Non-Small-Cell Lung 287 Prostatic Neoplasms 160 Colorectal Neoplasms 155 Carcinoma, Hepatocellular 142 Neoplasms 139 Leukemia, Myeloid, Acute 128 Lung Neoplasms 117 Multiple Myeloma 106 Squamous Cell Carcinoma of Head and Neck 105 Triple Negative Breast Neoplasms 97 Pancreatic Neoplasms 95 Recurrence 94 Stomach Neoplasms 93 Neoplasm Metastasis 92 Ovarian Neoplasms 86 Lymphoma, Large B-Cell, Diffuse 77 Sarcoma 73 Esophageal Neoplasms 71 Melanoma 70 Uterine Cervical Neoplasms 68 Precursor Cell Lymphoblastic Leukemia-Lymphoma 65 Brain Neoplasms 65 Rectal Neoplasms 61 Glioblastoma 61 Head and Neck Neoplasms 58 Carcinoma, Renal Cell 56 Myelodysplastic Syndromes 54 Leukemia, Lymphocytic, Chronic, B-Cell 53 Endometrial Neoplasms 53

Interventions

abemaciclib 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05872204 2025-03-19

ALEPRO

Universitaire Ziekenhuizen KU Leuven

Phase 2 Recruiting

Low Grade Serous Ovarian Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡